Press briefing on PRAC conclusions on signal of thromboembolic events with COVID-19 Vaccine Janssen
EventHumanCOVID-19Vaccines
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
- Tuesday, 20 April 2021, All day
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Jcovden (previously COVID-19 Vaccine Janssen) relating to cases of thromboembolic events by EMA’s safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC), on 20 April 2021.
Speakers:
- Ms Emer Cooke (Executive Director)
- Dr Sabine Straus (Chair of PRAC)
- Dr Peter Arlett (Head of Data Analytics and Methods Task Force).
The press briefing will be moderated by Ms Marie-Agnes Heine (Head of Communication).
The press briefing will be held in English.